Sehgal K, Serritella A, Liu M, ONeill A, et al. A phase I/II trial of sapanisertib in advanced anaplastic and radioiodine refractory differentiated thyroid carcinoma. J Clin Endocrinol Metab 2024 Jun 29:dgae443. doi: 10.1210.
PMID: 38943664